Rybak MJ - Search Results

1

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro B. Rybak MJ, et al. Clin Infect Dis. 2020 Sep 12;71(6):1361-1364. doi: 10.1093/cid/ciaa303. Clin Infect Dis. 2020. PMID: 32658968

2

CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Lamp KC, Bailey EM, Rybak MJ. Kaatz GW, et al. Among authors: rybak mj. Antimicrob Agents Chemother. 1992 Jun;36(6):1192-7. doi: 10.1128/AAC.36.6.1192. Antimicrob Agents Chemother. 1992. PMID: 1329613 Free PMC article.

3

Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.

Rybak MJ, Lerner SA, Levine DP, Albrecht LM, McNeil PL, Thompson GA, Kenny MT, Yuh L. Rybak MJ, et al. Antimicrob Agents Chemother. 1991 Apr;35(4):696-700. doi: 10.1128/AAC.35.4.696. Antimicrob Agents Chemother. 1991. PMID: 1829880 Free PMC article.

4

Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ. Kaatz GW, et al. Among authors: rybak mj. Antimicrob Agents Chemother. 1991 Aug;35(8):1547-50. doi: 10.1128/AAC.35.8.1547. Antimicrob Agents Chemother. 1991. PMID: 1929325 Free PMC article.

5

Vancomycin protein binding in patients with infections caused by Staphylococcus aureus.

Albrecht LM, Rybak MJ, Warbasse LH, Edwards DJ. Albrecht LM, et al. Among authors: rybak mj. DICP. 1991 Jul-Aug;25(7-8):713-5. doi: 10.1177/106002809102500701. DICP. 1991. PMID: 1949924

6

Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Reddy VN, Bailey EM, Rybak MJ. Kaatz GW, et al. Among authors: rybak mj. Antimicrob Agents Chemother. 1990 Nov;34(11):2081-5. doi: 10.1128/AAC.34.11.2081. Antimicrob Agents Chemother. 1990. PMID: 1963526 Free PMC article.

7

Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ. Kaatz GW, et al. Among authors: rybak mj. Antimicrob Agents Chemother. 1990 Feb;34(2):257-60. doi: 10.1128/AAC.34.2.257. Antimicrob Agents Chemother. 1990. PMID: 2327773 Free PMC article.

8

Nephrotoxicity of vancomycin, alone and with an aminoglycoside.

Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH. Rybak MJ, et al. J Antimicrob Chemother. 1990 Apr;25(4):679-87. doi: 10.1093/jac/25.4.679. J Antimicrob Chemother. 1990. PMID: 2351627

9

Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ. Kaatz GW, et al. Among authors: rybak mj. Antimicrob Agents Chemother. 1989 Apr;33(4):519-21. doi: 10.1128/AAC.33.4.519. Antimicrob Agents Chemother. 1989. PMID: 2499251 Free PMC article.

10

Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.

Chandrasekar PH, Levine DP, Price S, Rybak MJ. Chandrasekar PH, et al. Among authors: rybak mj. J Antimicrob Chemother. 1988 Apr;21(4):461-9. doi: 10.1093/jac/21.4.461. J Antimicrob Chemother. 1988. PMID: 3378959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page